Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Oct 26, 2023; 11(30): 7380-7385
Published online Oct 26, 2023. doi: 10.12998/wjcc.v11.i30.7380
Figure 2
Figure 2 Follow-up of medication dosage and pain level in the patient. A: Oral gabapentin 300 mg/d + lidocaine 5% patchs 1400 mg/d; B: Intracisternal hydromorphone (IH) 0.064 mg/d; C: IH 0.128 mg/d; D: IH 0.032 mg/d; EIH: End-of-intracisternal hydromorphone; Pre-op: Pre-opreation; NRS: Numeric rating scale.